Injectable nanoparticles that could protect an injured person from further damage due to oxidative stress have proven to be astoundingly effective in tests to study their mechanism.
Since day one at MIT, senior Yiping Xing has been interested in exploring medicine from different perspectives. Already, the biology major has co-authored two scientific papers, including a Nature Nanotechnology paper on siRNA delivery research; co-led a project in Ghana to convert organic waste into animal feed; and participated in national health policy through an internship in the U.S. Surgeon General’s office.
Gabriel Caballero Robledo from the Center for Research and Advanced Studies (CINVESTAV)at Monterrey, Mexico, is working on the design of a small medical device capable of detecting allergies or diseases quickly and at a low cost.
Researchers at Imperial College London and the Laboratoire de chimie de la matière condensée de Paris (CNRS/Collège de France/UPMC) have designed and developed hybrid gold-silica nanoparticles, which are turning out to be genuine therapeutic “Swiss Army knives”.
Better utilisation of mutual competencies, new knowledge, specific results and ultimately better and more effective drugs.
Hydrogels are materials that are commonly used in everyday objects such as contact lenses or diapers, in order to control humidity.
At the "Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor" recently held in Tianjin, the research team led by Professor Hao Jihui of the Pancreas Oncology Department of Tianjin Medical University Cancer Hospital announced that they had achieved a major breakthrough in the field of nano-carrier drugs for pancreatic cancer.
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company focused on the development and commercialization of lipid-based prescription therapeutics for the treatment of metabolic and cardiovascular conditions and the treatment of infectious diseases, announced today that it has acquired all of the outstanding stock of Aquarius BioTechnologies Inc. (Aquarius), an innovative bio-delivery drug discovery company with a novel and proprietary lipid-crystal nano-particle cochleate formulation technology platform.
When University of Maryland Professors Philip DeShong and Daniel Stein began tagging soap bubbles with biomolecules, they had no idea this technology would one day be poised to change the way drugs and vaccines fight against bacteria, viruses and cancer.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.